Base period award to inbios international, INC. For point-of-care immunoassay for diagnosis of inhalational anthrax

Active Definitive Contract Awarded Last action

Contract number
HHSO100201700029C
Awardee
Awarding agency
Obligated
$3,957,468

Award facts

Opportunity
Contract value 33% obligated
$12,051,614.00 Current and potential, with all options
Completion date 91% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Seattle, WA 98104, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 $0
Supplemental Agreement for work within scope P00010 $63,000
Supplemental Agreement for work within scope P00009 · Point-of-care immunoassay for diagnosis of inhalational anthrax $0
Supplemental Agreement for work within scope P00008 · The purpose of this bilateral modification is to revise a clerical error made in P00007. The fringe benefit rate cap for clin 2 was incorrectly set at 34% in… $0
Supplemental Agreement for work within scope P00007 $3,894,468
Other Administrative Action P00006 · The purpose of this bilateral modification is to change the contracting officer, change the COR & acor, change the requirement for electronic payment… $0
Supplemental Agreement for work within scope P00005 · No-cost supplemental agreement to extend to POP to 06/30/2023 due to civid -19 reprioritizations. No other changes apply. $0
Supplemental Agreement for work within scope P00004 · No-cost supplemental agreement to incorporate by executive order 14042 - far deviation clause 52.223-99, ensuring adequate covid safety protocols for federal… $0
Other Administrative Action P00003 · No-cost extension of period of performance from 9/22/2021 to 9/22/2022 to accommodate unforeseen delays and changes in the USG requirements to focus resources… $0
Other Administrative Action P00002 · No-cost extension of period of performance from 9/25/2020 to 9/22/2021, revised statement of work and gantt chart and change contracting officer from george… $0
Other Administrative Action 1 $0
Original award $0
Show all 12

About this award

Written by GovTribe AI ·

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $12.051 million definitive contract to Inbios International Inc., a minority-owned biotechnology company, for development of a point-of-care immunoassay for diagnosis of inhalational anthrax on September 26, 2017.

The contract carries no set-aside. Place of performance is Seattle, WA. Work extends through September 30, 2027 under cost-plus-fixed-fee pricing. In fiscal year 2024, the prime self-performed at 1.0 FTEs across 2,046 contractor hours at a derived government-paid rate of $134.65 per hour, invoicing $275 thousand in that period.

Quick answers

Who was awarded contract HHSO100201700029C?

HHSO100201700029C was awarded to Inbios International Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2017.

How much is contract HHSO100201700029C worth?

The government has obligated $3,957,468 on HHSO100201700029C. Its current value, with exercised options, is $12,051,614.

Was contract HHSO100201700029C competed?

The extent of competition for HHSO100201700029C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login